Downregulated cardiac annexin VI mRNA and protein levels in chronically fibrillating human atria

Cardiology

Volumn 109, Issue 3, 2008, Pages 208-216

  Ueng, Kwo Chang ^a   Lin, Chung Sheng ^a   Yeh, Hung I ^c,e   Wu, Yi Liang ^a   Liu, Rosa Huang ^b   Tsai, Chin Feng ^a   Tsai, Tsung Po ^a   Chen, Shih Ann ^d  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Annexin VI; Atrium; Calcium; Fibrillation; Remodeling

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALPHOBINDIN II; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MESSENGER RNA; RYANODINE RECEPTOR; SODIUM CALCIUM EXCHANGE PROTEIN;

AGED; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOWN REGULATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; MALE; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOLEMMA; SARCOPLASMIC RETICULUM; SINUS RHYTHM; WESTERN BLOTTING;

ACTINS; AGED; ANNEXIN A6; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; COMORBIDITY; DOWN-REGULATION; FEMALE; HUMANS; MALE; MICROSCOPY, CONFOCAL; POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 38949119515     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106685     Document Type: Article

References (18)

1. Schotten U, Ausma J, Stellbrink C, Sabatschus I, Vogel M, Frechen D, Schoendube F, Hanrath P, Allessie MA: Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 2001;103:691-698.
2. Leistad E, Aksnes G, Verburg E, Christensen G: Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. Circulation 1996;93:1747-1754.
3. Eisner DA, Choi HS, Díaz ME, O'Neill SC, Trafford AW: Integrative analysis of calcium cycling in cardiac muscle. Circ Res 2000;87:1087-1094.
4. Brundel BJ, van Gelder IC, Henning RH, Tuinenburg AE, Deelman LE, Tieleman RG, Grandjean JG, van Gilst WH, Crijns HJ: Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc Res 1999;42:443-454.
5. 2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol 1999;33:1231-1237.
6. Crompton MR, Moss SE, Crumpton MJ: Diversity in the lipocortin/calpactin family. Cell 1988;55:1-3.
7. Doubell AF, Lazure C, Charbonneau C, Thibault G: Identification and immunolocalization of annexins V and VI, the major cardiac annexins, in rat heart. Cardiovasc Res 1993;27:1359-1367.
8. Naciff JM, Behbehani MM, Kaetzel MA, Dedman JR: Annexin VI modulates Ca2+ and K+ conductances of spinal cord and dorsal root ganglion neurons. Am J Physiol Cell Physiol 1996;271:2004-2015.
9. Sobota A, Cusinato F, Luciani S: Identification and purification of calpactins from cardiac muscle and their effect on Na+/Ca2+ exchange activity. Biochem Biophys Res Commun 1990;172:1067-1072.
10. Diaz-Muñoz M, Hamilton SL, Kaetzel MA, Hazarika P, Dedman JR: Modulation of Ca2+ release channel activity from sarcoplasmic reticulum by annexin VI (67-kDa calcimedin). J Biol Chem 1990;265:15894-15899.
11. 2+-release channel requires intact annexin VI. J Cell Biochem 1991;46:86-93.
12. Gunteski-Hamblin AM, Song G, Walsh RA, Frenzke M, Boivin GP, Dorn GW 2nd, Kaetzel MA, Horseman ND, Dedman JR: Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice. Am J Physiol 1996;270:1091-1100.
13. Song G, Harding SE, Duchen MR, Tunwell R, O'Gara P, Hawkins TE, Moss SE: Altered mechanical properties and intracellular calcium signaling in cardiomyocytes from annexin 6 null-mutant mice. FASEB J 2002;16:622-624.
14. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
15. Trouvé P, Legot S, Bélikova I, Marotte F, Benevolensky D, Russo-Marie F, Samuel JL, Charlemagne D: Localization and quantitation of cardiac annexins II, V, and VI in hypertensive guinea pigs. Am J Physiol 1999;276:1159-1166.
16. Song G, Campos B, Wagoner LE, Dedman JR, Walsh RA: Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure. J Mol Cell Cardiol 1998;30:443-451.
17. Matteo RG, Moravec CS: Immunolocalization of annexins IV, V and VI in the failing and non-failing human heart. Cardiovasc Res 2000;45:961-970.
18. Li D, Fareh S, Leung TK, Nattel S: Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999;100:87-95.